Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

SF-36 health survey: Manual and interpretation guide

2003 • 11,679 citations

Bosentan Therapy for Pulmonary Arterial Hypertension

2002 • 2,715 citations

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

1996 • 2,590 citations

The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

1985 • 2,042 citations

Inhaled Iloprost for Severe Pulmonary Hypertension

2002 • 1,760 citations

Treatment of Pulmonary Arterial Hypertension

2004 • 1,673 citations

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

2001 • 1,521 citations

Pulmonary Arterial Hypertension

2004 • 1,457 citations

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension

2002 • 1,382 citations

A stagewise rejective multiple test procedure based on a modified Bonferroni test

1988 • 1,256 citations

Clinical Correlates and Prognostic Significance of Six-minute Walk Test in Patients with Primary Pulmonary Hypertension

2000 • 1,129 citations

Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease

2000 • 1,051 citations

Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology.

2004 • 1,041 citations

Diagnosis and differential assessment of pulmonary arterial hypertension

2004 • 1,000 citations

Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension

2000 • 881 citations

Medical Therapy For Pulmonary Arterial Hypertension

2004 • 853 citations

Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial

2002 • 639 citations

Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2

2004 • 632 citations

Beraprost therapy for pulmonary arterial hypertension

2003 • 627 citations

Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

2006 • 622 citations

The endothelin system in pulmonary arterial hypertension

2004 • 498 citations

Ambrisentan Therapy for Pulmonary Arterial Hypertension

2005 • 491 citations

Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist Sitaxsentan

2006 • 481 citations

Serum N-Terminal Brain Natriuretic Peptide as a Prognostic Parameter in Patients With Pulmonary Hypertension

2006 • 400 citations

ET_A and ET_B Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells

2002 • 310 citations

Clinical significance of brain natriuretic peptide in primary pulmonary hypertension

2004 • 286 citations

Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension

2004 • 256 citations

Effects of the thromboxane synthetase inhibitor and receptor antagonist terbogrel in patients with primary pulmonary hypertension

2002 • 82 citations

Introduction: new insights into a challenging disease

2004 • 50 citations

U.S. healthcare: the intertwined caduceus of physicians, coverage, quality, and cost

2004 • 14 citations